Submitted by dcc on Fri, 2023-12-01 11:48 Study Title: Phase II/III Second-Line NABPLAGEM vs. Nab-Paclitaxel/Gemcitabine in BRCA1/2 or PALB2 Mutant Metastatic Pancreatic Ductal Adenocarcinoma (PLATINUM)CIRB: Adult CIRB - Late Phase EmphasisLead Group: AllianceStatus: ActiveReview Status: Available to Open
